{"version":"1.0","provider_name":"CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores","provider_url":"https:\/\/cimti.cat\/es","author_name":"CIMTI","author_url":"https:\/\/cimti.cat\/es\/author\/elisenda\/","title":"RheoDx, an\u00e0lisis de sang port\u00e0tils - CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"AMuyECjxLs\"><a href=\"https:\/\/cimti.cat\/es\/rheodx-analisis-de-sang-portatils\/\">RheoDx, an\u00e0lisis de sang port\u00e0tils<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cimti.cat\/es\/rheodx-analisis-de-sang-portatils\/embed\/#?secret=AMuyECjxLs\" width=\"600\" height=\"338\" title=\"\u00abRheoDx, an\u00e0lisis de sang port\u00e0tils\u00bb \u2014 CIMTI.cat - Centre per a la Integraci\u00f3 de la Medicina i les Tecnologies Innovadores\" data-secret=\"AMuyECjxLs\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/*! This file is auto-generated *\/\n!function(c,d){\"use strict\";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},c.wp.receiveEmbedMessage);else if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(!t);else if(!(t.secret||t.message||t.value));else if(\/[^a-zA-Z0-9]\/.test(t.secret));else{for(var r,s,a,i=d.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),n=d.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),o=new RegExp(\"^https?:$\",\"i\"),l=0;l<n.length;l++)n[l].style.display=\"none\";for(l=0;l<i.length;l++)if(r=i[l],e.source!==r.contentWindow);else{if(r.removeAttribute(\"style\"),\"height\"===t.message){if(1e3<(s=parseInt(t.value,10)))s=1e3;else if(~~s<200)s=200;r.height=s}if(\"link\"===t.message)if(s=d.createElement(\"a\"),a=d.createElement(\"a\"),s.href=r.getAttribute(\"src\"),a.href=t.value,!o.test(a.protocol));else if(a.host===s.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener(\"message\",c.wp.receiveEmbedMessage,!1),d.addEventListener(\"DOMContentLoaded\",t,!1),c.addEventListener(\"load\",t,!1);function t(){if(o);else{o=!0;for(var e,t,r,s=-1!==navigator.appVersion.indexOf(\"MSIE 10\"),a=!!navigator.userAgent.match(\/Trident.*rv:11\\.\/),i=d.querySelectorAll(\"iframe.wp-embedded-content\"),n=0;n<i.length;n++){if(!(r=(t=i[n]).getAttribute(\"data-secret\")))r=Math.random().toString(36).substr(2,10),t.src+=\"#?secret=\"+r,t.setAttribute(\"data-secret\",r);if(s||a)(e=t.cloneNode(!0)).removeAttribute(\"security\"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:\"ready\",secret:r},\"*\")}}}}(window,document);\n<\/script>\n","description":"Anna Rodriguez 27.02.2019 05:30 h. Barcelona (VIAempresa) La startup impulsada per The Collider dissenya un dispositiu port\u00e0til que evitar\u00e0 la sobre prescripci\u00f3 de transfusions sangu\u00ednies Prevenir abans de curar. Aquesta hauria de ser la m\u00e0xima. \u00abActualment es realitzen 120 milions de transfusions l&#8217;any: un 20% d&#8217;elles s\u00f3n innecess\u00e0ries\u00bb, assenyala Oliver Balcells. L&#8217;emprenedor \u00e9s el CEO [&hellip;]","thumbnail_url":"https:\/\/www.viaempresa.cat\/uploads\/s1\/20\/69\/68\/53\/equip-de-rheodx_11_640x380.jpeg"}